Breast cancer detection with machine learning algorithms

Breast cancer, a predominant health crisis, notably stands as the second-highest cause of female mortality worldwide. Despite being one of the most common malignancies affecting women, it also poses a significant public health concern due to its complexity and high prevalence rate. Characterized by the unrestrained proliferation of breast cells, this condition affects both genders, albeit with a higher incidence in women, underlining its status as a pivotal global health issue. This study addresses the critical challenge of early breast cancer detection, a vital factor influencing survival rates. Traditional detection methods, including clinical breast examinations, mammography, and MRI, have limitations, particularly in terms of timeliness and early identification. To overcome these hurdles, our research introduces an innovative approach using machine learning, with a specific focus on ensemble methods. These methods are renowned for their capacity to enhance accuracy and efficacy in diagnostic procedures. The core of this study is the development and implementation of a neural network-based model. In this study, two datasets have been used first is the WBCD and the second is BRCA. This model demonstrates remarkable performance, outshining traditional methods with a striking accuracy rate of 98.18% for WBCD and 99.20% for BRCA. Such a high level of precision not only showcases the potential of machine learning in medical diagnostics but also emphasizes the necessity of integrating advanced technologies in healthcare practices. Finally, the findings of this research highlight the indispensable role of Information and Communication Technology (ICT) in healthcare, particularly in managing the vast volumes of medical data. The utilization of machine learning, especially ensemble methods, in breast cancer detection, presents a significant advancement, paving the way for more accurate, timely, and effective diagnosis and treatment strategies. This study not only contributes to the ongoing efforts in combating breast cancer but also sets a new benchmark in the application of technology in medical diagnostics.